Paco M J Welsing

Summary

Affiliation: Radboud University Nijmegen Medical Centre
Country: The Netherlands

Publications

  1. ncbi request reprint Modeling the 5-year cost effectiveness of treatment strategies including tumor necrosis factor-blocking agents and leflunomide for treating rheumatoid arthritis in the Netherlands
    Paco M J Welsing
    University Medical Center Nijmegen, Nijmegen, The Netherlands
    Arthritis Rheum 51:964-73. 2004
  2. ncbi request reprint Is the disease course of rheumatoid arthritis becoming milder? Time trends since 1985 in an inception cohort of early rheumatoid arthritis
    Paco M J Welsing
    Department of Rheumatology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
    Arthritis Rheum 52:2616-24. 2005
  3. ncbi request reprint The initial validation of a Markov model for the economic evaluation of (new) treatments for rheumatoid arthritis
    Paco M J Welsing
    Department of Rheumatology, Radboud University Medical Centre, Nijmegen, The Netherlands
    Pharmacoeconomics 24:1011-20. 2006
  4. ncbi request reprint Minimal clinically important difference in radiological progression of joint damage. A definition based on patient perspective
    Paco M J Welsing
    Department of Rheumatology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
    J Rheumatol 33:501-7. 2006
  5. ncbi request reprint The Nijmegen inception cohort of early rheumatoid arthritis
    Paco M J Welsing
    Department of Rheumatology, University Medical Centre Nijmegen, Nijmegen, The Netherlands
    J Rheumatol Suppl 69:14-21. 2004
  6. ncbi request reprint The relationship between disease activity and radiologic progression in patients with rheumatoid arthritis: a longitudinal analysis
    Paco M J Welsing
    University Medical Center Nijmegen, Nijmegen, The Netherlands
    Arthritis Rheum 50:2082-93. 2004
  7. ncbi request reprint An investigation of clinical studies suggests those with multiple objectives should have at least 90% power for each endpoint
    George F Borm
    Department of Epidemiology and Biostatistics, 133 EPIB, Radboud University Nijmegen Medical Centre, P O Box 9101, 6500HB Nijmegen, The Netherlands
    J Clin Epidemiol 59:1-6. 2006

Detail Information

Publications7

  1. ncbi request reprint Modeling the 5-year cost effectiveness of treatment strategies including tumor necrosis factor-blocking agents and leflunomide for treating rheumatoid arthritis in the Netherlands
    Paco M J Welsing
    University Medical Center Nijmegen, Nijmegen, The Netherlands
    Arthritis Rheum 51:964-73. 2004
    ..To determine the cost effectiveness of treatment strategies for rheumatoid arthritis patients satisfying the indication for tumor necrosis factor (TNF)-blocking treatment...
  2. ncbi request reprint Is the disease course of rheumatoid arthritis becoming milder? Time trends since 1985 in an inception cohort of early rheumatoid arthritis
    Paco M J Welsing
    Department of Rheumatology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
    Arthritis Rheum 52:2616-24. 2005
    ..This study was undertaken to investigate whether the course of disease activity and functional disability in patients with RA has become milder over the past several years...
  3. ncbi request reprint The initial validation of a Markov model for the economic evaluation of (new) treatments for rheumatoid arthritis
    Paco M J Welsing
    Department of Rheumatology, Radboud University Medical Centre, Nijmegen, The Netherlands
    Pharmacoeconomics 24:1011-20. 2006
    ..Moreover, we perform an initial validation of this model...
  4. ncbi request reprint Minimal clinically important difference in radiological progression of joint damage. A definition based on patient perspective
    Paco M J Welsing
    Department of Rheumatology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
    J Rheumatol 33:501-7. 2006
    ..To validate existing estimates of minimal clinically important difference (MCID) using this relation with functional disability...
  5. ncbi request reprint The Nijmegen inception cohort of early rheumatoid arthritis
    Paco M J Welsing
    Department of Rheumatology, University Medical Centre Nijmegen, Nijmegen, The Netherlands
    J Rheumatol Suppl 69:14-21. 2004
    ..These instruments are described and results of studies are discussed concerning prognostic and predictive factors, disease course, and the relationship between the different process and outcome measures...
  6. ncbi request reprint The relationship between disease activity and radiologic progression in patients with rheumatoid arthritis: a longitudinal analysis
    Paco M J Welsing
    University Medical Center Nijmegen, Nijmegen, The Netherlands
    Arthritis Rheum 50:2082-93. 2004
    ....
  7. ncbi request reprint An investigation of clinical studies suggests those with multiple objectives should have at least 90% power for each endpoint
    George F Borm
    Department of Epidemiology and Biostatistics, 133 EPIB, Radboud University Nijmegen Medical Centre, P O Box 9101, 6500HB Nijmegen, The Netherlands
    J Clin Epidemiol 59:1-6. 2006
    ..We investigated the overall power of a study, that is, the probability that all the objectives will be met...